Advertisement

Drugs & Therapy Perspectives

, Volume 4, Issue 11, pp 7–8 | Cite as

Olanzapine: set to fulfil its atypical potential

New Drugs and Therapeutics
  • 3 Downloads

References

  1. 1.
    Hall R. Inpharma 953: 8–9, 1994CrossRefGoogle Scholar
  2. 2.
    Fitton A, Heel RC. Drugs 40: 722–747, 1990PubMedCrossRefGoogle Scholar
  3. 3.
    Lieberman JA, Alvir JM. Drug Saf 7 (Suppl. 1): 1–2, 1992PubMedCrossRefGoogle Scholar
  4. 4.
    Moore NA, et al. Drugs Fut 19: 114–117, 1994Google Scholar
  5. 5.
    Moore NA, et al. J Pharmacol Exp Ther 262: 545–551, 1992PubMedGoogle Scholar
  6. 6.
    Moore NA, et al. Behav Pharmacol 5: 196–202, 1994PubMedCrossRefGoogle Scholar
  7. 7.
    Obermeyer BD, et al. Pharmacologist 35: 176, 1993Google Scholar
  8. 8.
    Beasley CM, et al. Neuropsychopharmacology 10 (Suppl. 1): 536, 1994Google Scholar
  9. 9.
    Tran PV, et al. Neuropsychopharmacology 10 (Suppl. 2): 267, 1994Google Scholar
  10. 10.
    Tollefson GD, et al. Biol Psychiatry 35: 746–747, 1994CrossRefGoogle Scholar

Copyright information

© Adis International Limited 1994

Personalised recommendations